Koios Medical, Inc.

Koios Medical is a healthcare technology company that develops FDA-cleared, CE-marked AI-powered software for ultrasound image analysis, focusing on early detection of breast and thyroid cancers. The company's proprietary SmartUltrasound® platform (Koios DS™) leverages deep learning algorithms trained on over 500,000 breast lesion ultrasound images to provide clinical decision support for radiologists and sonographers. The platform assists in detecting, classifying, and characterizing suspicious lesions, reducing missed cancers by approximately 10x while improving workflow efficiency. Koios Medical operates on an annual subscription model and partners with major OEMs including GE Healthcare and Philips for distribution across 101+ installation sites in 28 countries. The company's AI-driven approach enhances diagnostic accuracy and supports billable ultrasound procedures, enabling healthcare facilities to streamline cancer detection workflows.